Md Yuzaiful Md Yusof
Md Yuzaiful Md Yusof
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
Verified email at
Cited by
Cited by
Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre
MY Md Yusof, A Kabia, M Darby, G Lettieri, P Beirne, EM Vital, S Dass, ...
Rheumatology 56 (8), 1348-1357, 2017
A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features
YM El-Sherbiny, A Psarras, MY Md Yusof, EMA Hensor, R Tooze, ...
Scientific reports 8 (1), 5793, 2018
Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus
MYM Yusof, D Shaw, YM El-Sherbiny, E Dunn, AC Rawstron, P Emery, ...
Annals of the rheumatic diseases 76 (11), 1829-1836, 2017
Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status
MYM Yusof, A Psarras, YM El-Sherbiny, EMA Hensor, K Dutton, ...
Annals of the rheumatic diseases 77 (10), 1432-1439, 2018
Brief report: responses to rituximab suggest B cell–independent inflammation in cutaneous systemic lupus erythematosus
EM Vital, M Wittmann, S Edward, MY Md Yusof, H MacIver, CT Pease, ...
Arthritis & Rheumatology 67 (6), 1586-1591, 2015
Targeting interleukin-6 in rheumatoid arthritis
MY Md Yusof, P Emery
Drugs 73, 341-356, 2013
Predicting severe infection and effects of hypogammaglobulinemia during therapy with rituximab in rheumatic and musculoskeletal diseases
MY Md Yusof, EM Vital, DM McElvenny, EMA Hensor, S Das, S Dass, ...
Arthritis & Rheumatology 71 (11), 1812-1823, 2019
The role of ultrasound in assessing musculoskeletal symptoms of systemic lupus erythematosus: a systematic literature review
AS Zayat, MY Md Yusof, RJ Wakefield, PG Conaghan, P Emery, EM Vital
Rheumatology 55 (3), 485-494, 2016
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity
A Psarras, A Alase, A Antanaviciute, IM Carr, MY Md Yusof, M Wittmann, ...
Nature communications 11 (1), 6149, 2020
Primary myocardial disease in scleroderma—a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group
LA Bissell, MY Md Yusof, MH Buch
Rheumatology 56 (6), 882-895, 2017
Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions
MYM Yusof, EM Vital, S Das, S Dass, G Arumugakani, S Savic, ...
Annals of the rheumatic diseases 74 (9), 1734-1738, 2015
Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus
AS Zayat, K Mahmoud, MY Md Yusof, S Mukherjee, MA D’Agostino, ...
Rheumatology 58 (2), 304-312, 2019
Certolizumab pegol in rheumatoid arthritis: current update
M Fechtenbaum, MY Md Yusof, P Emery
Expert opinion on biological therapy 14 (6), 841-850, 2014
Lessons for rituximab therapy in patients with rheumatoid arthritis
L Garcia-Montoya, C Villota-Eraso, MYM Yusof, EM Vital, P Emery
The Lancet Rheumatology 2 (8), e497-e509, 2020
B cell therapies, approved and emerging: a review of infectious risk and prevention during use
MY Md Yusof, EM Vital, MH Buch
Current rheumatology reports 17, 1-12, 2015
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a …
MYM Yusof, J Arnold, B Saleem, C Vandevelde, S Dass, S Savic, EM Vital, ...
The Lancet Rheumatology 5 (2), e88-e98, 2023
B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus
YM El‐Sherbiny, MY Md Yusof, A Psarras, EMA Hensor, KZ Kabba, ...
Arthritis & Rheumatology 72 (5), 769-779, 2020
Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus
K Mahmoud, AS Zayat, Y Yusof, E Hensor, PG Conaghan, P Emery, ...
Rheumatology 58 (8), 1353-1360, 2019
B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: current progress
MY Md Yusof, EMJ Vital, P Emery
Expert review of clinical immunology 9 (8), 761-772, 2013
Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab
J Arnold, S Dass, S Twigg, CH Jones, B Rhodes, P Hewins, ...
Rheumatology 61 (12), 4905-4909, 2022
The system can't perform the operation now. Try again later.
Articles 1–20